Myovant Sciences Ltd.
MYOVDelisted Mar 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001679082
Myovant Sciences Ltd. was delisted on Mar 10, 2023; its insiders filed their last Form 4 on Mar 10, 2023; 118 institutions reported holding it in 13F filings for Q4 2022, worth $1.12B in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Myovant Sciences Ltd. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- +7 vs. Q2 2022
- Shares held
- 28.5M
- −1.25M (−4.2%) vs. Q2 2022
- Total value
- $511.5M
- +$142.2M (+38.5%) vs. Q2 2022
- New holders
- 29
- 26 more added
- Sold out
- 22
- 25 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MYOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $27 |
| Q1 2026 | 1 | $27 |
| Q4 2025 | 1 | $27 |
| Q3 2025 | 1 | $27 |
| Q2 2025 | 1 | $27 |
| Q1 2025 | 1 | $27 |
| Q4 2024 | 1 | $27 |
| Q3 2024 | 1 | $27 |
| Q2 2024 | 1 | $27 |
| Q1 2024 | 1 | $27 |
| Q4 2023 | 1 | $27 |
| Q3 2023 | 1 | $27 |
| Q2 2023 | 1 | $27 |
| Q1 2023 | 2 | $27 |
| Q4 2022 | 118 | $1.12B |
| Q3 2022 | 98 | $511.5M |
| Q2 2022 | 91 | $369.3M |
| Q1 2022 | 89 | $400.0M |
| Q4 2021 | 110 | $475.6M |
| Q3 2021 | 105 | $677.6M |
| Q2 2021 | 108 | $736.6M |
| Q1 2021 | 104 | $623.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Myovant Sciences Ltd.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −84,086−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −73,528−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −48,119−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −47,300−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −34,590−100.0% | Sold out |
| Tarbox Family Office, Inc. | 0 | $0 | 0.00% | −27,500−100.0% | Sold out |
| CWA Asset Management Group, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −19,907−100.0% | Sold out |
| Bourgeon Capital Management LLC | 0 | $0 | 0.00% | −15,200−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −13,744−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −11,198−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −10,396−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −10,323−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −7,730−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −4,600−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −2,276−100.0% | Sold out |
| SeaCrest Wealth Management, LLC | 0 | $0 | 0.00% | −2,050−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Vectors Research Management, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |